site stats

Forastiere j clin oncol 1992

WebForastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus … WebDec 5, 1994 · Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma J Clin Oncol. 1994 May;12(5):946-53.doi: 10.1200/JCO.1994.12.5.946. Authors S G Urba 1 , A A Forastiere, G T Wolf, R M Esclamado, P W McLaughlin, A F Thornton Affiliation

UpToDate

WebSummary. Francesco Forastiere, MD, Ph.D, is with the National Research Council (CNR) in Palermo, Italy and is visiting professor at Imperial College, London. He has served for 37 … WebBurtness, B.A.; Manola, J.; Axelrod, R.; Argiris, A.; Forastiere, A.A. A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study. Ann Oncol. 2008 May;19 (5):977-983. greenhithe to canary wharf https://cecassisi.com

An intergroup phase III comparison of standard radiation …

WebOct 8, 1992 · DOI: 10.1200/JCO.1992.10.8.1245 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 1634913 Randomized comparison of … WebJan 18, 2012 · J Clin Oncol. 1992;10(2):257–63. PubMed CAS Google Scholar Forastiere AA, Metch B, Schuller DE, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. WebApr 1, 1992 · A phase I and pharmacologic study was undertaken to determine the maximum-tolerated dose (MTD), describe the principal toxicities, and characterize the pharmacologic behavior of topotecan, which is a semisynthetic analog of camptothecin with broad preclinical antitumor activity and the first topoisomerase I-targeting agent to enter … greenhithe to bluewater

Concurrent Chemotherapy and Radiotherapy for Organ …

Category:Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk

Tags:Forastiere j clin oncol 1992

Forastiere j clin oncol 1992

An intergroup phase III comparison of standard radiation ... - PubMed

WebSep 21, 2016 · Forastiere AA, Metch B, Schuller DE, et al: Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in … WebSep 21, 2016 · Arlene A. Forastiere. Search for articles by this author. ... Results: Between 1992 and 1999, 295 patients were entered on this trial. This did not meet the accrual goal of 362 patients and resulted in premature study closure. ... DOI: 10.1200/JCO.2003.01.008 Journal of Clinical Oncology 21, no. 1 (January 01, 2003) 92-98. Published online ...

Forastiere j clin oncol 1992

Did you know?

WebApr 1, 1992 · Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 01 Apr 1992, 10(4): 647-656 DOI: 10.1200/jco.1992.10.4.647 PMID: … WebOct 2, 1992 · J Clin Oncol. 1992 Feb;10(2):282-91. doi: ... B J Roth 1 , D H Johnson, L H Einhorn, L P Schacter, N C Cherng, H J Cohen, J Crawford, J A Randolph, J L Goodlow, G O Broun, et al. Affiliation 1 Department of Medicine, Indiana University School of Medicine, Indianapolis. PMID: 1310103 DOI: 10.1200 ...

WebFeb 27, 2024 · J Clin Oncol 1992; 10:257. Morton RP, Rugman F, Dorman EB, et al. Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial. Cancer Chemother Pharmacol 1985; 15:283. ... J Clin Oncol 2004; 22:262. Forastiere AA, Leong T, Rowinsky E, et al. … WebApr 12, 2024 · Journal of Clinical Oncology (JCO) is a high-impact, peer-reviewed medical journal that publishes significant clinical oncology research along with editorials, reviews, and other works that relate to the care of patients with cancer.

WebSep 1, 2007 · Purpose: Taxane-based concurrent chemoradiotherapy (CCR) for head and neck cancers has proven to have a favorable toxicity profile compared with cisplatin and radiation. This phase II multi-institutional trial evaluates taxane-based induction chemotherapy followed by CCR for organ preservation in resectable stage III/IVA and … WebThyroid gland is an uncommon site of metastasis, and metastasis to the gland secondary to nasopharyngeal carcinoma is seldom seen. We were only able to identify eight reported cases in the literature. A 61-year-old man, diagnosed case of

WebApr 11, 2024 · TP53 mutations are less frequent in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) than in solid tumors, except in secondary and therapy-related MDS/AMLs, and in cases with complex monosomal karyotype. As in solid tumors, missense mutations predominate, with the same hotspot mutated codons (particularly codons 175, …

WebNov 10, 1993 · Purpose: To determine the maximum-tolerated doses (MTD), the principal toxicities, and the pharmacologic behavior of high doses of Taxol (paclitaxel; Bristol-Myers Squibb, New York, NY) combined with cisplatin and granulocyte colony-stimulating factor (G … greenhithe to dartford train timesWebSep 1, 2013 · A.A. Forastiere, B. Metch, D.E. Schuller, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study ... J Clin Oncol, 10 (1992), pp. 1245-1251. View Record in Scopus Google Scholar. 4. flx waller txWebApr 4, 2024 · A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck … greenhithe to dartford trainWebMay 20, 2005 · J Clin Oncol. 2005 May 20;23(15):3562-7. doi: ... Ronald C DeConti, John Ensley, Arlene A Forastiere; Eastern Cooperative Oncology Group. Affiliation 1 Department of Medical Oncology, Sidney Kimmell Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21231, USA. [email protected]; greenhithe to gillinghamWebCisplatin plus 5-fluorouracil (5-FU) (PF regimen) induction chemotherapy (IC) has been studied over the last two decades and has proven to be a durable and effective therapy for patients with locally advanced squamous cell cancer of the head and neck (SCCHN). Although randomized trials and meta-analyses have demonstrated that PF-based IC … greenhithe to guildfordWebApr 2, 2024 · Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adaptive particle radiotherapy. Clin Transl Radiat Oncol. 2024 Nov 11;32:35-40. doi: 10.1016/j.ctro.2024.11.003. eCollection 2024 Jan. greenhithe to gatwickWebOct 4, 1992 · J Clin Oncol. 1992 Apr;10(4):647-56. doi: ... C B Hendricks, D S Ettinger, A A Forastiere, L A Hurowitz, W P McGuire, S E Sartorius, B G Lubejko, S H Kaufmann, et al. Affiliation 1 Johns Hopkins Oncology Center, Division of Pharmacology and Experimental Therapeutics, Baltimore, MD 21205. greenhithe to liverpool street